The Valley Desk

ArticleClinical lung cancerPublished

Chemoimmunotherapy vs. Immunotherapy for First Line Treatment of Advanced Non-small Cell Lung Cancer With a PD-L1 Expression ≥50% or ≥90

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Clinical lung cancer
Published
Subject terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Immunotherapy; Cohort Studies; Antineoplastic Agents, Immunological; B7-H1 Antigen; advanced lung cancer; First Line Therapy; Real-world Study; New User Active Comparator
PubMed ID
36935244
PubMed Central ID
PMC10149619
Added to directory
Source checked

Report a correction or request removal